#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primitive neuroectodermal tumour Medulloblastoma recurrent Phenylketonuria Canavan disease Hydrocephalus Ichthyosis Red blood cell abnormality Post transplant lymphoproliferative disorder Anti-neutrophil cytoplasmic antibody positive vasculitis Marginal zone lymphoma refractory Peritoneal neoplasm Hormone-dependent prostate cancer Hypersensitivity pneumonitis Cholestatic pruritus Alexander disease More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Basic Information Pemphigoid – Basic Information Haemophilia B with anti factor IX – Trials in Disease Optic glioma – Life with Disease Adrenogenital syndrome – Treatment Alexander disease Atypical haemolytic uraemic syndrome – Life with Disease Rosai-Dorfman syndrome Burkitt’s lymphoma Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valproate Semisodium Albumin Mps-214 Cloxacillin 4-Hydroxy-N-Desmethyltamoxifen Bimekizumab Ecubectedin Carbidopa Incb099280 Azd3427 Bms-986288 Bisoprolol Fumarate Metyrapone Latozinemab Sirolimus Lovastatin Streptococcus Agalactiae Mk-4830 Secale Cereale Nazartinib More therapies…

    Learn about Your Condition

    Escherichia infection Gastrointestinal disorder Acquired ATTR amyloidosis Osteosarcoma metastatic Acute leukaemia Metastatic glioma Staphylococcal bacteraemia Malignant neoplasm of choroid Penile squamous cell carcinoma Menopausal symptoms Mitral valve disease Aplasia pure red cell Acute on chronic liver failure Vulvovaginal discomfort Endometrial adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Alergo-Med Specjalistyczna Przychodnia Lekarska Sp….

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z o.o.

Pjn 2r Siwiapa Tehjlnd 3mvqxig Pvcatt

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Respiratory tract infection
    Investigated Drugs:
    • Haemophilus Influenzae
    • Staphylococcus Aureus
    • Streptococcus Pneumoniae
    Poland

  • A study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Loratadine
    Bulgaria Germany Poland Spain

  • Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

    Recruiting

    2 1
    Belgium Bulgaria Czechia Hungary Italy Poland +1

  • Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Salbutamol
    • Glycopyrronium Bromide
    • Fluticasone Propionate
    Bulgaria Hungary Poland Spain

  • Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tezepelumab
    France Hungary Italy The Netherlands Poland Romania +1

  • Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    Bulgaria France Germany Italy Poland Romania +2

  • Study on Eblasakimab for Adults with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Germany Poland

  • Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Placebo
    Austria Germany Poland

  • A study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Bulgaria Czechia Germany Hungary Poland

  • Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Rocatinlimab
    Croatia Czechia Germany Greece Hungary Italy +6
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!